Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1161/STROKEAHA.118.021380

Type

Journal article

Journal

Stroke

Publication Date

05/2018

Volume

49

Pages

e174 - e199

Keywords

alleles, cognition, gait, quality of life, white matter, Antibodies, Monoclonal, Humanized, Anticoagulants, Antidotes, Antihypertensive Agents, Arginine, Delivery of Health Care, Factor Xa, Health Policy, Humans, Hypertension, Intracranial Hemorrhages, Outcome Assessment (Health Care), Piperazines, Recombinant Proteins, Stroke, Stroke Rehabilitation, Thrombectomy, Thrombolytic Therapy